side effects glp 1 agonist Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus Adverse effects of GLP-1 class

In the LEAD-6 clinical study, which lasted for 26 weeks, the efficacy of liraglutide with background metformin and/or sulfonylurea therapy was compared with that of twice-daily exenatide6)

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis

A drug that produces greater average weight loss may not deliver better outcomes if it is less well tolerated by a specific patient

SURMOUNT-5-Studie: Tirzepatid (Mounjaro) Die SURMOUNT-5-Studie verglich direkt die Wirkung von Tirzepatid (Mounjaro) mit Semaglutid (Wegovy)

Encouraged by such results, Saxenda expanded its indication to adolescent patients aged 12-18 with BMI equivalent to 30kg/ adults and weighing 60kg or more in December 2021

Potential Side Effects and Prevalence Like any medication, there is an inherent risk of adverse effects, and unfortunately, with this class of medications, they are quite common